Shareholders' Equity (Details) - USD ($)		1 Months Ended						3 Months Ended
	Nov. 30, 2000	Apr. 30, 2024	Apr. 30, 2023	Mar. 31, 2022	Apr. 30, 2021	Nov. 30, 2015	Nov. 30, 2000	Feb. 28, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	Nov. 30, 2024	Feb. 29, 2024	Oct. 31, 2016	Aug. 31, 2010	Feb. 29, 1996
Shareholders’ Equity [Line Items]
Preferred stock, shares authorized								5,000,000					5,000,000
Cumulative dividends per shares (in Dollars per share)	$ 0.50
Dividends (in Dollars)								$ 174,069
Aggregate of common shares
Total of shares issued		5,085
Cost of issuance (in Dollars)										$ 97,500
Exercise price (in Dollars per share)
Grant date expire				5 years
Granting cost (in Dollars)				$ 492,132
Intrinsic value of exercisable options (in Dollars)								$ 137,950
Weighted average remaining life								1 year 2 months 12 days
Unrecognized compensation cost (in Dollars)
Director [Member]
Shareholders’ Equity [Line Items]
Compensation (in Dollars)								3,000
Board of Directors Chairman [Member]
Shareholders’ Equity [Line Items]
Compensation (in Dollars)								$ 4,000
Series C Preferred Stock [Member]
Shareholders’ Equity [Line Items]
Preferred stock, shares authorized	100,000						100,000	100,000					100,000
Shares of our common stock	10						10
Preferred stock issued in payment							70,000
Preferred shares, issued								10,000					10,000
Preferred shares, outstanding								10,000					10,000
Series D Preferred Stock [Member]
Shareholders’ Equity [Line Items]
Preferred stock, shares authorized								75,000					75,000		75,000
Preferred shares, issued
Preferred shares, outstanding
2015 Incentive Stock Plan [Member]
Shareholders’ Equity [Line Items]
Total of shares issued			28,179		26,786						26,000
Cost of issuance (in Dollars)									$ 15,000			$ 75,000
2015 Incentive Stock Plan [Member] | Share-Based Payment Arrangement, Option [Member]
Shareholders’ Equity [Line Items]
Aggregate of common shares						1,500,000
2024 Incentive Stock Plan [Member]
Shareholders’ Equity [Line Items]
Number of common shares authorized for purchase for grant of options													1,000,000
Number of common shares grants
Preferred Stock [Member]
Shareholders’ Equity [Line Items]
Preferred stock, shares authorized																5,000,000	1,000,000
Four Non-Employee Directors [Member]
Shareholders’ Equity [Line Items]
Aggregate of common shares				20,000
One Non-Employee Director [Member]
Shareholders’ Equity [Line Items]
Aggregate of common shares				30,000
Two Company Officers [Member]
Shareholders’ Equity [Line Items]
Aggregate of common shares				40,000
Exercise price (in Dollars per share)				$ 3.55